Sutro Biopharma, Inc. (NasdaqGM:STRO) Value Composite Score Update

Checking in on some valuation rankings, Sutro Biopharma, Inc. (NasdaqGM:STRO) has a Value Composite score of 89. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 87. 

Investors may be trying to decide if the current market environment remains bullish. It can be extremely difficult to decide when to sell, especially when data seems positive and most signs are pointing higher. Jumping in to buy stocks on a pullback may seem like a good idea, but following specific sectors may become increasingly more important. Following long-term trends may help the investor see the bigger picture of what has been going on with a specific stock or sector. Deciding to sell a winner after a big run can be tempting, but knowing the underlying causes for the run may help identify if there may indeed be more room for gains. Avoiding common investing pitfalls may take many years to master, but it may end up determining long-term success.  

In taking a look at some other notable technicals, Sutro Biopharma, Inc. (NasdaqGM:STRO)’s ROIC is -0.612672. The ROIC 5 year average is and the ROIC Quality ratio is . ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helps show how efficient a firm is at turning capital into profits.

The Q.i. Value of Sutro Biopharma, Inc. (NasdaqGM:STRO) is 88.  The Q.i. Value is a helpful tool in determining if a company is undervalued or not.  The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity.  The lower the Q.i. value, the more undervalued the company is thought to be.

The FCF Yield 5yr Average is calculated by taking the five year average free cash flow of a company, and dividing it by the current enterprise value.  Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents.  The average FCF of a company is determined by looking at the cash generated by operations of the company.  The Free Cash Flow Yield 5 Year Average of Sutro Biopharma, Inc. (NasdaqGM:STRO) is . 

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Shareholder Yield
We also note that Sutro Biopharma, Inc. (NasdaqGM:STRO) has a Shareholder Yield of -0.004557 and a Shareholder Yield (Mebane Faber) of 0.00282. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second value adds in the net debt repaid yield to the calculation. Shareholder yield has the ability to show how much money the firm is giving back to shareholders via a few different avenues. Companies may issue new shares and buy back their own shares. This may occur at the same time. Investors may also use shareholder yield to gauge a baseline rate of return.

MF Rank
Sutro Biopharma, Inc. (NasdaqGM:STRO) has a current MF Rank of 16504. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

PI
We can now take aquick look at some historical stock price index data. Sutro Biopharma, Inc. (NasdaqGM:STRO) presently has a 10 month price index of 1.03954. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period.

A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 1.04762, the 24 month is 0.70921, and the 36 month is 0.70921. Narrowing in a bit closer, the 5 month price index is 0.94728, the 3 month is 1.32108, and the 1 month is currently 1.08451.

Coming up with a viable and solid stock investment plan might be on the minds of many individual investors. A solid plan might entail defining the overall objective and recognizing tangible restraints. Figuring out these details may help the investor focus on the most important aspects of investing in the stock market. Following strategies set forth by others may work, but they may also leave the investor in a quandary. What worked in the past for one person may not work in the future for another. Investors may need to craft the plan keeping in mind the long-term goals. Although some investors and traders focus on the short-term, many investors are more interested in making the grade over a number of years, and not a number of days or months. Plans may need to be set up so that they are flexible and have the ability to withstand unforeseen shifts and rapidly changing stock market scenarios. Flexibility may end up being the key to a successful plan down the road. Investors may also want to do regular check-ins on portfolio performance in order to keep tabs on how well the plan is working.

Leave a Reply

Your email address will not be published. Required fields are marked *

*